Format

Send to

Choose Destination
Arch Intern Med. 2011 Mar 28;171(6):591-3. doi: 10.1001/archinternmed.2011.89.

The FDA drug safety surveillance program: adverse event reporting trends.

Author information

1
Center for Drug Safety, Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA. sweiss@rx.umaryland.edu
PMID:
21444854
DOI:
10.1001/archinternmed.2011.89
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center